Colvin Richard A 4
4 · bluebird bio, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Colvin Richard A
Chief Medical Officer
Transactions
- Award
Common Stock
2024-09-30+50,000→ 168,368 total
Footnotes (1)
- [F1]These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of March 1, 2025, March 1, 2026, March 1, 2027 and March 1, 2028. These restricted stock units were approved during the Issuer's regular annual review cycle for 2024 with a delayed date of issuance.